UnitedHealth has entered into a $ 4.9 billion agreement to acquire DaVita, the DaVita kidney dialysis unit of the DaVita Medical group in a cash transaction.
Others in the industry are now competing to take a page from the Optum playbook.
This week, the pharmaceutical benefits firm CVS reached an agreement of $ 60 billion to buy Aetna, in a An attempt was made to create an integrated system of benefits and vertical medical care that would be anchored around CVS stores and pharmacies. Companies say they can provide consumers with better coordinated care and more profitable.
While the two firms have very little agreement, the proposed CVS-Aetna merger could face some regulatory scrutiny due to the scale of the agreement. So far, that type of health care model has generally been used by hospital systems such as Geisinger Health and Kaiser Permanente.
DaVita said he plans to focus on his kidney care business for now and use the proceeds from the sale for "significant share repurchases" after the transaction closes, according to the companies' announcement.
Even so, the company does not plan to be an independent business for long, in an environment where there is pressure to provide greater value in health care.
"We also hope to look for other investments in out-of-care health care services. kidney, "said Thiry.